VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog๐ŸคPartner
Illustration for: Morgan Stanley Files Amended S-1s for Solana and Ethereum Trusts, Widening the Crypto-ETF Door
Value Add VC/Pulse/IPOS-1/A filed

Morgan Stanley Files Amended S-1s for Solana and Ethereum Trusts, Widening the Crypto-ETF Door

Morgan Stanley filed amended S-1 registration statements for both a Solana Trust and an Ethereum Trust with the SEC, pushing a blue-chip Wall Street name deeper into spot-crypto products beyond Bitcoin. The filings signal that institutional crypto access is broadening from BTC into the next tier of large-cap tokens.

By the Numbers

Morgan Stanley
Filer
Solana + Ethereum Trusts
Products
S-1/A (amended)
Filing
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
June 18, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

A bulge-bracket bank packaging Solana and Ether into regulated trusts mainstreams crypto exposure beyond Bitcoin

2

Amended S-1s typically mean a filing is advancing through SEC review, not stalling

3

Solana getting institutional ETF treatment validates the 'alt-L1' thesis for allocators

4

It deepens the on-ramp connecting traditional finance balance sheets to digital assets

TC

The VC Read ยท Trace's Take

Trace Cohen

Bitcoin ETFs were the wedge; this is the door swinging wider. When Morgan Stanley is filing amended S-1s for Solana and Ether trusts, the question has shifted from 'will crypto get institutional access' to 'which tokens get it next' -- and Solana making the cut validates the alt-L1 trade for allocators who couldn't touch it before. The real story for founders is distribution: regulated wrappers from trusted names are how trillions in traditional capital actually reach this asset class. Watch the SEC review timeline -- that's the gating function on the next leg of institutional flows.

๐Ÿ“ˆ 2026 IPO Tracker โ†’๐Ÿ“Š IPO Pipeline โ†’

Analysis

Morgan Stanley filed amended S-1 registration statements with the SEC for a Solana Trust and an Ethereum Trust, advancing its push into spot-crypto investment products beyond Bitcoin. Amended filings generally indicate a registration is moving through the regulatory review process, a step toward bringing regulated, exchange-listed crypto exposure to institutional and retail investors.

The significance is the issuer. When a bulge-bracket Wall Street institution wraps assets like Solana and Ether into regulated trust structures, it signals that crypto exposure is being normalized as a mainstream allocation rather than a fringe bet. Bitcoin ETFs broke the seal; extending the same treatment to the next tier of large-cap tokens widens the door considerably.

โ€œBitcoin ETFs broke the seal; extending the same treatment to the next tier of large-cap tokens widens the door considerably.โ€

For the digital-asset market, Solana receiving institutional ETF packaging is a notable validation of the 'alternative layer-1' thesis -- the idea that value will accrue to more than just Bitcoin and Ethereum. As these products move through SEC review, they deepen the on-ramp between traditional finance and crypto, channeling regulated capital into assets that, until recently, most institutions couldn't easily hold.

ShareXLinkedInEmail

More on

Morgan Stanley โ†’

Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPOยท Aug 4, 2026

The Anthropic-OpenAI IPO Race, Scored

Illustration for: The Anthropic-OpenAI IPO Race, Scored
IPO

The Anthropic-OpenAI IPO Race, Scored

Anthropic confidentially filed for IPO first, at a $965B valuation on a $47B revenue run rate -- but OpenAI's IPO pipeline is also active, and the two companies are now effectively racing to define what an AI-lab public listing should look like.

IPOยท Aug 4, 2026

Tech's Biotech IPO Window Is Quietly Reopening

Illustration for: Tech's Biotech IPO Window Is Quietly Reopening
IPO

Tech's Biotech IPO Window Is Quietly Reopening

While tech IPOs grab headlines, this week's actual new listings are almost entirely biotech -- a sign the broader IPO window is widening beyond the handful of AI mega-caps everyone's watching.

IPOยท Aug 4, 2026

Cerebras, Three Months Public: The Scorecard

Illustration for: Cerebras, Three Months Public: The Scorecard
IPO

Cerebras, Three Months Public: The Scorecard

Cerebras went public in May at a $56.43B implied valuation, becoming the market's clearest test case for whether a pure-play AI chip challenger to Nvidia can hold a premium multiple once quarterly numbers replace private-market narrative.

@Trace_Cohenยทt@nyvp.com